Access and Equity Issues The high cost of novel glucagon-like peptide-1 receptor agonist class agents often limits access and creates barriers to care [62]
Addionally, the VA announced on September 25, 2024, that it will conduct a scientific assessment to explore a potential link between PFAS exposure during military service and kidney cancer
Nicholas, Giving Dowry to Three Poor Girls, painting by Fra Angelico / WikiArt Subscribe by email to follow the accumulating evidence and observations that shape our view of health, obesity, and policy.
The Urbina 2026 review reported GLP-1 users showing 2630% lower ferritin levels than SGLT2 inhibitor comparators
2024 Apr 12;10(4):1327-1338
And absolutely, hes correct